<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03414164</url>
  </required_header>
  <id_info>
    <org_study_id>UHR-12</org_study_id>
    <nct_id>NCT03414164</nct_id>
  </id_info>
  <brief_title>In Vitro Effects of Procyanidine on Semen Parameter and DFI</brief_title>
  <official_title>In Vitro Effects of Procyanidine on Semen Parameters and DNA Fragmentation Index: a Prospective, Double-blind Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Proanthocyanidins are a class of polyphenols found in a variety of plants that have
      antioxidant activity in vitro, which is stronger than vitamin C or vitamin E.

      Several studies have been performed evaluating the administration of antioxidant therapy in
      the form of oral antioxidant supplementation or in vitro addition of antioxidant to culture
      media during assisted reproductive techniques (ART).

      However, the impact of in vitro addition of proanthocyanidins to semen has not been studied
      yet. The research question evaluated in the current study was whether semen samples of
      infertile men supplemented or not with procyanidine immediately after their production,
      differ in semen parameters, sperm DFI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 29, 2017</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">November 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progressive sperm motility</measure>
    <time_frame>3h after addition or not of procyanidine</time_frame>
    <description>percentage (%) of decrease</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sperm DNA fragmentation index</measure>
    <time_frame>3h after addition or not of procyanidine</time_frame>
    <description>percentage (%) of decrease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm morphology</measure>
    <time_frame>3h after addition or not of procyanidine</time_frame>
    <description>percentage (%) of decrease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sperm vitality</measure>
    <time_frame>3h after addition or not of procyanidine</time_frame>
    <description>percentage (%) of decrease</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Spermatogenesis and Semen Disorders</condition>
  <condition>DNA Double Strand Break</condition>
  <arm_group>
    <arm_group_label>procyanidine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>procyanidine</intervention_name>
    <description>natural antioxidants</description>
    <arm_group_label>procyanidine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infertility defined as:

               -  At least twelve (12) months of non-achieving pregnancy despite unprotected sexual
                  intercourse or six (6) months, if the female is &gt; 35 years of age AND

               -  At least two (2) semen analyses with at least one abnormal parameter (sperm
                  concentration, motility and morphology), according to WHO 2010 criteria.

          -  Not on any type of infertility treatment for the last three (3) months

          -  Sperm concentration &gt; 8 x 106/ml and semen volume at least 2.5 ml for technical
             reasons.

          -  Normal hormonal profile (TSH, FSH, LH, total testosterone, prolactin)

          -  Seminal white blood cells &lt; 1 x 106/ml

          -  No abnormalities in scrotal ultrasound

        Exclusion Criteria:

          -  Underlying genetic cause of infertility

          -  History of undescended testis (cryptorchidism)

          -  History of orchidectomy

          -  History of testicular cancer

          -  History of severe cardiac, hepatic or renal disease.

          -  History of endocrine disease (primary or secondary hypogonadism, hyperprolactinemia,
             thyroid disease, pituitary or adrenal disease)

          -  History of epididymo-orchitis, prostatitis, genital trauma, testicular torsion,
             inguinal or genital surgery

          -  History of systemic disease or treatment during the last three (3) months

          -  Positive sperm culture for Chlamydia or Ureaplasma urealyticum

          -  Female infertility factors

          -  Body mass index (BMI) &gt; 30 kg/m2

          -  Participation in another interventional study and a likelihood of being unavailable
             for follow-up.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Stratis Kolibianakis</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54603</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2017</study_first_submitted>
  <study_first_submitted_qc>January 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2018</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aristotle University Of Thessaloniki</investigator_affiliation>
    <investigator_full_name>E.M. Kolibianakis</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Procyanidin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

